BJDX
Bluejay Diagnostics, Inc.
Price Chart
Latest Quote
$4.44
-0.10 (-2.20%)
Current Price
| Previous Close | $4.54 |
| Open | $4.40 |
| Day High | $4.57 |
| Day Low | $4.24 |
| Volume | 35,305 |
Stock Information
| Shares Outstanding | 1.03M |
| Total Debt | $101K |
| Cash Equivalents | $3.68M |
| Net Income | $-6.90M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $4.59M |
| EPS (TTM) | $-3.74 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.11M |
| Income | $-6.90M |
| Book/sh | $4.04 |
| Cash/sh | $3.56 |
| Employees | 6 |
Financial Ratios
| Quick Ratio | 2.61 |
| Current Ratio | 2.81 |
| Debt/Eq | 2.40 |
Returns & Margins
| ROA | -79.65% |
| ROE | -171.56% |
Ownership
| Insider Ownership | 6.07% |
| Institutional Ownership | 10.62% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -13.88 |
| P/B | 1.10 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $3.63 |
| SMA50 | $2.57 |
| SMA200 | $4.16 |
| RSI | 69.76 |
| ATR | 0.9576 |
| Shares Float | 880K |
| Short Float | 3.20% |
| Short Ratio | 0.45 |
| Volatility | 0.82 |
| Rel Volume | 0.01 |
Performance History
| Week | -1.11% |
| Month | +158.14% |
| Quarter | +140.00% |
| 6 Months | +8.82% |
| YTD | +69.47% |
| Year | -33.93% |
| 3 Years | -99.94% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $4.44 | 35,400 |
| 2026-06-16 | $4.54 | 93,600 |
| 2026-06-15 | $4.80 | 61,700 |
| 2026-06-12 | $4.89 | 62,900 |
| 2026-06-11 | $4.74 | 54,200 |
| 2026-06-10 | $4.49 | 107,000 |
| 2026-06-09 | $4.50 | 142,800 |
| 2026-06-08 | $5.23 | 193,300 |
| 2026-06-05 | $4.80 | 718,000 |
| 2026-06-04 | $5.30 | 2,349,000 |
| 2026-06-03 | $4.51 | 1,107,700 |
| 2026-06-02 | $4.34 | 74,419,100 |
| 2026-06-01 | $2.17 | 74,200 |
| 2026-05-29 | $2.14 | 109,600 |
| 2026-05-28 | $2.18 | 499,700 |
| 2026-05-27 | $1.96 | 215,100 |
| 2026-05-26 | $1.93 | 102,000 |
| 2026-05-22 | $1.92 | 35,300 |
| 2026-05-21 | $1.95 | 97,600 |
| 2026-05-20 | $1.78 | 15,500 |
| 2026-05-19 | $1.71 | 20,300 |
| 2026-05-18 | $1.72 | 35,500 |
About Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $249,040 |
| Operating Revenue | $0 | $0 | $0 | $249,040 |
| Reconciled Cost Of Revenue | - | - | $0 | $200,129 |
| Cost Of Revenue | - | - | $0 | $200,129 |
| Expenses | ||||
| Interest Expense | $839 | $823,028 | $0 | $0 |
| Total Expenses | $6,952,972 | $7,169,616 | $10,311,217 | $9,566,816 |
| Other Income Expense | $7,769 | $129,027 | $192,429 | $-68,845 |
| Other Non Operating Income Expenses | $7,769 | $129,027 | $192,429 | $168,464 |
| Net Non Operating Interest Income Expense | $96,720 | $-677,205 | $164,900 | $89,673 |
| Interest Expense Non Operating | $839 | $823,028 | $0 | $0 |
| Operating Expense | $6,952,972 | $7,169,616 | $10,311,217 | $9,366,687 |
| Selling And Marketing Expense | $0 | $8,297 | $283,443 | $451,421 |
| General And Administrative Expense | $3,906,524 | $3,689,648 | $4,313,200 | $4,763,114 |
| Other Operating Expenses | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-6,848,483 | $-7,717,794 | $-9,953,888 | $-9,296,948 |
| Net Interest Income | $96,720 | $-677,205 | $164,900 | $89,673 |
| Interest Income | $97,559 | $145,823 | $164,900 | $89,673 |
| Normalized Income | $-6,848,483 | $-7,717,794 | $-9,953,888 | $-9,059,639 |
| Net Income From Continuing And Discontinued Operation | $-6,848,483 | $-7,717,794 | $-9,953,888 | $-9,296,948 |
| Total Operating Income As Reported | $-6,952,972 | $-7,169,616 | $-10,311,217 | $-9,317,776 |
| Net Income Common Stockholders | $-6,848,483 | $-20,940,847 | $-9,953,888 | $-9,296,948 |
| Net Income | $-6,848,483 | $-7,717,794 | $-9,953,888 | $-9,296,948 |
| Net Income Including Noncontrolling Interests | $-6,848,483 | $-7,717,794 | $-9,953,888 | $-9,296,948 |
| Net Income Continuous Operations | $-6,848,483 | $-7,717,794 | $-9,953,888 | $-9,296,948 |
| Pretax Income | $-6,848,483 | $-7,717,794 | $-9,953,888 | $-9,296,948 |
| Interest Income Non Operating | $97,559 | $145,823 | $164,900 | $89,673 |
| Operating Income | $-6,952,972 | $-7,169,616 | $-10,311,217 | $-9,317,776 |
| Special Income Charges | - | - | $0 | $-237,309 |
| Gross Profit | - | - | $0 | $48,911 |
| Per Share | ||||
| Diluted EPS | $-15.25 | $-456.75 | $-12860.32 | $-14733.67 |
| Basic EPS | $-15.25 | $-456.75 | $-12860.32 | $-14733.67 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-6,676,963 | $-6,695,669 | $-9,172,933 | $-8,774,099 |
| Reconciled Depreciation | $170,681 | $199,097 | $780,955 | $306,368 |
| EBITDA (Bullshit earnings) | $-6,676,963 | $-6,695,669 | $-9,172,933 | $-9,011,408 |
| EBIT | $-6,847,644 | $-6,894,766 | $-9,953,888 | $-9,317,776 |
| Diluted Average Shares | $449,043 | $45,848 | $774 | $631 |
| Basic Average Shares | $449,043 | $45,848 | $774 | $631 |
| Diluted NI Availto Com Stockholders | $-6,848,483 | $-20,940,847 | $-9,953,888 | $-9,296,948 |
| Otherunder Preferred Stock Dividend | $0 | $13,223,053 | $0 | - |
| Research And Development | $3,046,448 | $3,471,671 | $5,714,574 | $4,152,152 |
| Selling General And Administration | $3,906,524 | $3,697,945 | $4,596,643 | $5,214,535 |
| Other Gand A | $3,906,524 | $3,689,648 | $4,313,200 | $4,763,114 |
| Total Unusual Items | - | - | $0 | $-237,309 |
| Total Unusual Items Excluding Goodwill | - | - | $0 | $-237,309 |
| Impairment Of Capital Assets | - | - | $0 | $237,309 |
| Other Special Charges | - | - | - | - |
| Gain On Sale Of Security | - | - | - | - |
Fetched: 2026-06-16
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $5,975,289 | $5,729,499 | $2,894,848 | $11,541,273 |
| Total Assets | $7,119,237 | $6,657,423 | $4,868,531 | $13,521,265 |
| Total Non Current Assets | $1,655,635 | $1,758,540 | $1,647,671 | $1,732,795 |
| Other Non Current Assets | $7,905 | $35,257 | $28,663 | $35,211 |
| Current Assets | $5,463,602 | $4,898,883 | $3,220,860 | $11,788,470 |
| Assets Held For Sale Current | $22,770 | $0 | - | - |
| Prepaid Assets | $275,957 | $596,938 | $695,301 | $1,433,197 |
| Cash Cash Equivalents And Short Term Investments | $5,164,875 | $4,301,945 | $2,208,516 | $10,114,990 |
| Cash And Cash Equivalents | $5,164,875 | $4,301,945 | $2,208,516 | $10,114,990 |
| Other Current Assets | - | $85,818 | $51,962 | $240,283 |
| Current Deferred Assets | - | $0 | $265,081 | $0 |
| Goodwill And Other Intangible Assets | - | - | - | $4,457 |
| Other Intangible Assets | - | - | - | $4,457 |
| Inventory | - | - | - | - |
| Debt | ||||
| Total Debt | $120,211 | $222,249 | $352,977 | $492,621 |
| Long Term Debt And Capital Lease Obligation | $20,211 | $108,989 | $189,987 | $323,915 |
| Current Debt And Capital Lease Obligation | $100,000 | $113,260 | $162,990 | $168,706 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,143,948 | $927,924 | $1,973,683 | $1,979,992 |
| Total Non Current Liabilities Net Minority Interest | $24,751 | $117,556 | $202,308 | $339,738 |
| Other Non Current Liabilities | $4,540 | $8,567 | $12,321 | $15,823 |
| Current Liabilities | $1,119,197 | $810,368 | $1,771,375 | $1,640,254 |
| Payables And Accrued Expenses | $1,019,197 | $697,108 | $1,608,385 | $1,471,548 |
| Payables | $214,255 | $145,122 | $491,474 | $635,818 |
| Accounts Payable | $214,255 | $145,122 | $491,474 | $635,818 |
| Current Notes Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $5,975,289 | $5,729,499 | $2,894,848 | $11,541,273 |
| Total Equity Gross Minority Interest | $5,975,289 | $5,729,499 | $2,894,848 | $11,541,273 |
| Stockholders Equity | $5,975,289 | $5,729,499 | $2,894,848 | $11,541,273 |
| Retained Earnings | $-41,517,267 | $-34,668,784 | $-26,950,990 | $-16,997,102 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $604,534 | $138,503 | $774 | $631 |
| Share Issued | $604,534 | $138,503 | $774 | $631 |
| Tangible Book Value | $5,975,289 | $5,729,499 | $2,894,848 | $11,541,273 |
| Invested Capital | $5,975,289 | $5,729,499 | $2,894,848 | $11,541,273 |
| Working Capital | $4,344,405 | $4,088,515 | $1,449,485 | $10,148,216 |
| Capital Lease Obligations | $120,211 | $222,249 | $352,977 | $492,621 |
| Total Capitalization | $5,975,289 | $5,729,499 | $2,894,848 | $11,541,273 |
| Additional Paid In Capital | $47,492,496 | $40,398,269 | $29,845,838 | $28,538,274 |
| Capital Stock | $60 | $14 | $0 | $101 |
| Common Stock | $60 | $14 | $0 | $101 |
| Long Term Capital Lease Obligation | $20,211 | $108,989 | $189,987 | $323,915 |
| Current Capital Lease Obligation | $100,000 | $113,260 | $162,990 | $168,706 |
| Current Accrued Expenses | $804,942 | $551,986 | $1,116,911 | $835,730 |
| Net PPE | $1,647,730 | $1,723,283 | $1,619,008 | $1,697,584 |
| Accumulated Depreciation | $-144,617 | $-194,952 | $-1,243,716 | $-596,406 |
| Gross PPE | $1,792,347 | $1,918,235 | $2,862,724 | $2,293,990 |
| Leases | $43,231 | $43,231 | $43,231 | $43,231 |
| Construction In Progress | $1,279,173 | $1,351,179 | $1,052,822 | $375,466 |
| Other Properties | $353,161 | $383,056 | $1,621,050 | $1,733,894 |
| Machinery Furniture Equipment | $116,782 | $140,769 | $145,621 | $141,399 |
| Properties | $0 | $0 | $0 | $0 |
| Buildings And Improvements | - | - | $333,267 | $465,514 |
| Treasury Shares Number | - | - | - | $0 |
| Dueto Related Parties Current | - | - | - | - |
Fetched: 2026-06-16
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-6,227,310 | $-8,127,605 | $-9,018,036 | $-8,940,863 |
| Operating Activities | ||||
| Operating Cash Flow | $-6,053,575 | $-7,820,822 | $-8,313,870 | $-7,741,593 |
| Cash Flow From Continuing Operating Activities | $-6,053,575 | $-7,820,822 | $-8,313,870 | $-7,741,593 |
| Operating Gains Losses | $42,937 | $3,411 | $1,787 | $137 |
| Investing Activities | ||||
| Capital Expenditure | $-173,735 | $-306,783 | $-704,166 | $-1,199,270 |
| Investing Cash Flow | $-173,735 | $-306,783 | $-704,166 | $-1,199,270 |
| Cash Flow From Continuing Investing Activities | $-173,735 | $-306,783 | $-704,166 | $-1,199,270 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $8,346,692 | $12,069,075 | $1,590,840 | $0 |
| Financing Cash Flow | $7,090,240 | $10,221,034 | $1,111,562 | $8,075 |
| Cash Flow From Continuing Financing Activities | $7,090,240 | $10,221,034 | $1,111,562 | $8,075 |
| Net Other Financing Charges | $-1,252,425 | $-1,844,845 | $-474,471 | $-20,000 |
| Net Common Stock Issuance | $8,346,692 | $12,069,075 | $1,590,840 | $0 |
| Common Stock Issuance | $8,346,692 | $12,069,075 | $1,590,840 | $0 |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-4,027 | $-2,003,754 | $-4,807 | $-801 |
| Issuance Of Debt | $0 | $2,000,000 | $0 | $0 |
| End Cash Position | $5,164,875 | $4,301,945 | $2,208,516 | $10,114,990 |
| Beginning Cash Position | $4,301,945 | $2,208,516 | $10,114,990 | $19,047,778 |
| Changes In Cash | $862,930 | $2,093,429 | $-7,906,474 | $-8,932,788 |
| Proceeds From Stock Option Exercised | $0 | $558 | $0 | $28,876 |
| Net Issuance Payments Of Debt | $-4,027 | $-3,754 | $-4,807 | $-801 |
| Net Long Term Debt Issuance | $-4,027 | $-3,754 | $-4,807 | $-801 |
| Long Term Debt Payments | $-4,027 | $-2,003,754 | $-4,807 | $-801 |
| Long Term Debt Issuance | $0 | $2,000,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-173,735 | $-306,783 | $-704,166 | $-1,199,270 |
| Purchase Of PPE | $-173,735 | $-306,783 | $-704,166 | $-1,199,270 |
| Change In Working Capital | $581,284 | $-633,193 | $666,726 | $578,537 |
| Change In Other Current Assets | $27,352 | $-6,594 | $6,548 | $-14,192 |
| Change In Payables And Accrued Expense | $220,051 | $-1,042,005 | $-266,039 | $633,501 |
| Change In Accrued Expense | $150,918 | $-695,653 | $-30,279 | $336,620 |
| Change In Payable | $69,133 | $-346,352 | $-235,760 | $296,881 |
| Change In Account Payable | $69,133 | $-346,352 | $-235,760 | $298,881 |
| Change In Prepaid Assets | $333,881 | $150,325 | $926,217 | $-40,772 |
| Stock Based Compensation | $6 | $20,094 | $189,245 | $433,004 |
| Depreciation Amortization Depletion | $170,681 | $199,097 | $780,955 | $306,368 |
| Depreciation And Amortization | $170,681 | $199,097 | $780,955 | $306,368 |
| Depreciation | $170,681 | $199,097 | $780,955 | $306,368 |
| Gain Loss On Sale Of PPE | $42,937 | $3,411 | $1,787 | $137 |
| Net Income From Continuing Operations | $-6,848,483 | $-7,717,794 | $-9,953,888 | $-9,296,948 |
| Change In Other Working Capital | - | $265,081 | - | - |
| Other Non Cash Items | - | $307,563 | $1,305 | - |
| Interest Paid Supplemental Data | - | - | $1,305 | $364 |
| Asset Impairment Charge | - | - | $1,787 | $237,309 |
| Change In Inventory | - | - | - | $0 |
| Change In Receivables | - | - | - | - |
| Changes In Account Receivables | - | - | - | - |
| Gain Loss On Investment Securities | - | - | - | - |
Fetched: 2026-06-16